伴侣动物药品市场规模、份额和成长分析（按宠物类型、药物类别、分销管道和地区划分）－2026-2033年产业预测

预计到 2024 年，伴侣动物药品市场规模将达到 168.7 亿美元，到 2025 年将达到 180.2 亿美元，到 2033 年将达到 305 亿美元，在预测期（2026-2033 年）内，复合年增长率为 6.8%。

全球伴侣动物药品市场正经历强劲成长，这主要得益于宠物饲养量的增加、宠物保健意识的提高以及兽医学的进步。随着越来越多的家庭饲养宠物，对犬猫等动物的药物和治疗方法需求也日益增长。市场的主要驱动因素包括预防性护理（包括疫苗接种和寄生虫防治）的普及以及慢性病治疗方案的多样化。药物传递方式和製剂的创新，例如调味片和外用药物，提高了给药的便利性。随着宠物饲主越来越重视宠物的健康，伴侣动物药品市场预计将持续成长，为製药公司和兽医在这个蓬勃发展的领域带来巨大的机会。

伴侣动物药品市场驱动因素

受兽医学进步的推动，伴侣动物药品市场正经历显着成长。这些创新包括更有效的诊断方法、治疗方法和药物的研发，大大丰富了可供选择的治疗方案。疾病管理策略的改进和治疗效果的提升也是推动这一趋势的关键因素。随着兽医和宠物饲主逐渐认识到先进医疗方案的益处，对专用于伴侣动物的先进药物的需求也不断增长。兽医学的全面进步进一步巩固了高品质药物在拓展市场和促进动物健康方面的重要性。

伴侣动物医药市场限制因素

伴侣动物药品市场面临巨大的挑战，这主要是由于动物医药和治疗带来的经济负担。高昂的费用使得饲主难以重视宠物的健康，导致他们延后必要的医疗照护。这种经济障碍在低收入社区和预算有限的饲主中尤为突出，他们可能难以负担昂贵的宠物医疗保健费用。因此，伴侣动物药品的高昂价格阻碍了市场普及，并最终威胁到宠物的健康和福祉。

伴侣动物医药市场趋势

伴侣动物医疗市场正呈现出显着的数位化健康解决方案整合趋势，这正在革新兽医护理。穿戴式装置和行动应用程式的普及使饲主能够远端监测宠物的健康状况，从而加强预防性护理并及早发现潜在问题。远距医疗服务日益普及，促进了饲主与兽医之间的即时沟通，并改善了处方笺和治疗方案的管理。这种向技术主导医疗保健的转变不仅简化了兽医护理流程，也赋予了饲主更多自主权，并反映出市场对全面便捷的宠物护理解决方案日益增长的重视。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 专利分析

全球伴侣动物药品市场规模（依宠物类型划分）及复合年增长率（2026-2033 年）

• 狗
• 猫
• 马
• 其他的

全球伴侣动物药品市场规模（按药物类别和复合年增长率划分）（2026-2033 年）

• 抗生素
• 抗发炎药
• 治疗犬心丝虫的药物
• 驱虫药
• 营养药物
• 行为药物
• 疫苗
• 其他的

全球伴侣动物药品市场规模（依通路划分）及复合年增长率（2026-2033 年）

• 兽医院药房
• 电子商务
• 零售药房

全球伴侣动物药品市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Zoetis（USA）
• Elanco Animal Health（USA）
• Virbac（France）
• Ceva Sante Animale（France）
• Boehringer Ingelheim（Germany）
• Merck Animal Health（USA）
• Bayer Animal Health（Germany）
• Kemin Industries（USA）
• Hester Biosciences（India）
• Vetoquinol（France）
• Dechra Pharmaceuticals（UK）
• IDEXX Laboratories（USA）
• Mars Petcare（USA）
• Nestle Purina Petcare（Switzerland）
• Hill's Pet Nutrition（USA）
• Boehringer Ingelheim Vetmedica（Germany）
• MSD Animal Health（USA）
• Bayer HealthCare Animal Health（Germany）
• Virbac Animal Health（France）
• Ceva Animal Health（France）

结论与建议

Companion Animal Drugs Market size was valued at USD 16.87 Billion in 2024 and is poised to grow from USD 18.02 Billion in 2025 to USD 30.5 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global companion animal drugs market is witnessing robust expansion, fueled by increasing pet ownership, heightened awareness of pet healthcare, and advancements in veterinary pharmaceuticals. As more households embrace pet companionship, there is a rising demand for various medications and treatments for animals such as dogs and cats. Key market drivers include a shift toward preventive care, encompassing vaccinations and parasite management, along with a growing array of therapeutic options for chronic conditions. Innovations in drug delivery methods and formulations, such as flavored tablets and topical treatments, are improving administration ease. With pet owners prioritizing their animals' health, the companion animal drugs market is set for continued growth, presenting significant opportunities for pharmaceutical companies and veterinarians in this thriving sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Companion Animal Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Companion Animal Drugs Market Segments Analysis

Global Companion Animal Drugs Market is segmented by Companion Animals, Drug Class, Distribution Channel and region. Based on Companion Animals, the market is segmented into Dogs, Cats, Horses and Others. Based on Drug Class, the market is segmented into Antibiotics, Anti-inflammatory, Heart Worm Drugs,parasiticides, Nutritional Drugs, Behavioral Drugs, Vaccines and Others. Based on Distribution Channel, the market is segmented into Veterinary Pharmacies, E-commerce and Retail Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Companion Animal Drugs Market

The companion animal drugs market is experiencing significant growth, driven by advancements in veterinary medicine. These innovations encompass the creation of more effective diagnostics, treatments, and pharmaceuticals, which have greatly enriched the variety of available therapeutic options. Enhanced disease management strategies and increased treatment efficacy are also pivotal developments contributing to this trend. As veterinarians and pet owners recognize the benefits of improved medical solutions, there is a heightened demand for sophisticated medications tailored to companion animals. This overall progress in veterinary care is further solidifying the market's expansion and the importance of high-quality pharmaceuticals in promoting animal health.

Restraints in the Companion Animal Drugs Market

The Companion Animal Drugs market is encountering significant challenges due to the financial strain associated with veterinary medicines and treatments. High costs can deter pet owners from prioritizing their animals' health, leading to delays in seeking necessary medical care. This financial barrier is particularly pronounced among pet owners in low-income areas or those operating on tight budgets, as they may struggle to afford these expensive healthcare options for their pets. As a result, the substantial expense associated with companion animal medications can impede widespread market adoption and ultimately compromise the health and well-being of pets.

Market Trends of the Companion Animal Drugs Market

The Companion Animal Drugs market is experiencing a notable trend towards the integration of digital health solutions, which are revolutionizing veterinary care. The rise of wearable devices and mobile applications allows pet owners to remotely monitor their animals' health, enhancing proactive care and early detection of potential issues. Telehealth services are becoming increasingly popular, facilitating real-time communication between pet owners and veterinarians, thus improving the management of prescriptions and treatment plans. This shift towards technology-driven healthcare not only streamlines the veterinary experience but also empowers pet owners, reflecting a growing emphasis on holistic and accessible pet care solutions in the marketplace.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Companion Animal Drugs Market Size by Companion Animals & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Horses
• Others

Global Companion Animal Drugs Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Antibiotics
• Anti-inflammatory
• Heart Worm Drugs
• Parasiticides
• Nutritional Drugs
• Behavioral Drugs
• Vaccines
• Others

Global Companion Animal Drugs Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Pharmacies
• E-commerce
• Retail Pharmacies

Global Companion Animal Drugs Market Size & CAGR (2026-2033)

• North America (Companion Animals, Drug Class, Distribution Channel)
  • US
  • Canada
• Europe (Companion Animals, Drug Class, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Companion Animals, Drug Class, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Companion Animals, Drug Class, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Companion Animals, Drug Class, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mars Petcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Purina Petcare (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hill's Pet Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Vetmedica (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer HealthCare Animal Health (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac Animal Health (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Animal Health (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations